Purchase Order N3239825P0101

This federal contract award to Biofire Defense LLC, a for-profit limited liability company, is for the delivery of the NGDS-ASY-0017 product, which is part of the Biofire Defense line of biological agent identification systems. The $18,034.00 firm fixed price purchase order was awarded on December 3, 2024 by the U.S. Navy's Bureau of Medicine and Surgery, a defense agency, with a period of performance through February 28, 2025. This award is not associated with a set-aside program. Biofire Defense has a history of providing diagnostic assays, test kits, and testing platforms like the FilmArray system to various Department of Defense and other federal agencies for biodefense, infectious disease testing, and public health preparedness efforts.